AVR

2.27%

$9.00 anteris technologies ltd

Global future, page-49

First 49 Last

Share
Profile

Follow
axman

705 Posts.

24

27/10/15

10:30

Post #: 16260226
Share

Originally posted by tomboy ↑

Heres some sample AGM questions:-
- to Catlow & Rowley - why did AF sell his shares at the peak SP of 17c last year? And why did Emichrome sell their shares at 11c? You know them both well, tell us all why?
- so you boys made $20M to $30M in FMG, so why has this SP collapsed 2 years in a a row being the worst BIOASX performer since 2013?
- Where are the Canada & Asia CC sale results and why cant the TGA approve CC here?
- Why are the expenses still exceeding the income?
- to all those holders who paid $32M cash for CR at 7c and have lost $Millions in value, what message do you have for them as to why they should continue to lose $Millions investing in AHZ?
- If CC is so good why are the expenses still lower than the costs
- Pr Frazer stated there was massive partnering interest on the clinical results that was 3 years ago, where is all that interest now at Phase 2
- what are the Phase 2 results and why did Frazer say they were similar to the clinical & animal testing results in his Youtube video in June posted on HC? Did he pre-release these results & do you agree with Pr Frazer's results he stated in that video?
- Since March when the first 2 cohorts where injected with monthly vaccines, with now over 8 monthly injections since, shold not the results of these injections been known to you and AV labs by June already and why are you witholding these results released already to the market by Pr Frazer in June?
- what is the status of the court proceedings re Regen?
- To Rodne, in your Morgans Video in Sept 2014 you promised us LTHs major news over the next 6 months, that was over 14 months ago, did you really mean that major news was a large cheap CR that would collapse the SP to 6c from 15c and make us all lose 66% of our share value and if not then what other news were you referring to then?
- why have you or Pr Frazers shutdown research into skin cancer and HIV & HepC as mentioned by Proactive Investors in 2013?
- In Feb 2014 you announced a joint CSIRO research into Adapt/CC expnaded uses, why has that secret report not been released to the public for now over 19 months ago and what if any are the results of this research or has CSIRO deliberately kept them secret from you and from the market?
- Why are these pipelines of numerous undisclosed CC ADAPT & AVaccine products kept secret from the market and why not disclose those products and research?
- In 2014 you announced HPV Phase 1 trials, why have these trials taken over 2 years and havent even started yet?
- What do you hope to achieve in a 1-10 consolidation?
- Why did Pr Frazer inject his Mice with 500 times the lethal dose of the HSV2 antivirus? Was that a defacto human sample trial that was successful.
- Are you opening a clean room no 4 at the malaga factory hence all those renovation works there for the last 6 months?
- why didnt AF take shares in the 7c CR in Feb? Why isnt he on the Board
- Why are you hiding the HSV2 phase 2 results since June?

Would I get kicked out of the AGM for these questions, should i ask them? The WASPS/oldies will have a heart attack.

Expand

Finally a post from you that is not over the top hype, well done! Ask these Q's, most of us would be very appreciative.

AHZ Price at posting: 6.6¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

First 49 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $9.00		Change 0.200(2.27%)		Mkt cap ! $190.2M

Open	High	Low	Value	Volume
$8.90	$9.48	$8.88	$176.7K	19.75K

Buyers (Bids)

No.	Vol.	Price($)
2	590	$8.80

Sellers (Offers)

Price($)	Vol.	No.
$9.40	70	1

View Market Depth

No.	Vol.	Price($)
2	590	8.800
2	2067	8.680
1	260	8.510
1	300	8.500
1	2	8.420

Price($)	Vol.	No.
9.400	70	1
9.430	105	1
9.490	218	1
9.500	250	1
9.850	1000	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)

AVR (ASX) Chart

Global future, page-49

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Global future, page-49

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News